{
    "cas_no": "57-64-7",
    "key_name": "(-)-Physostigmine salicylate",
    "cn_name": null,
    "alternate_name": "Benzoic acid, 2-hydroxy-, compd. with (3a<em>S</em>,8a<em>R</em>)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-<em>b</em>]indol-5-yl <em>N</em>-methylcarbamate (1:1);Physostigmine salicylate;Physostigmine, monosalicylate;Benzoic acid, 2-hydroxy-, compd. with (3a<em>S</em>-<em>cis</em>)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-<em>b</em>]indol-5-yl methylcarbamate (1:1);Benzoic acid, 2-hydroxy-, compd. with (3a<em>S</em>,8a<em>R</em>)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-<em>b</em>]indol-5-yl methylcarbamate (1:1);Salicylic acid, compd. with physostigmine (1:1);Pyrrolo[2,3-<em>b</em>]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3a<em>S</em>-<em>cis</em>)-, mono(2-hydroxybenzoate) (salt);Pyrrolo[2,3-<em>b</em>]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3a<em>S</em>,8a<em>R</em>)-, mono(2-hydroxybenzoate) (salt);Eserine salicylate;(-)-Physostigmine salicylate;Isopto Eserine",
    "duplicated_cas_no": "11033-04-8;11036-66-1",
    "SMILES": "C(O)(=O)C1=C(O)C=CC=C1.C[C@]12C=3C(N(C)[C@]1(N(C)CC2)[H])=CC=C(OC(NC)=O)C3",
    "meta_data": {
        "InChI": "InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1",
        "InChIKey": null,
        "Canonical SMILES": "O=C(O)C=1C=CC=CC1O.O=C(OC1=CC=C2C(=C1)C3(C)CCN(C)C3N2C)NC",
        "Molecular Formula": "C<sub>15</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>.C<sub>7</sub>H<sub>6</sub>O<sub>3</sub>",
        "Molecular Mass": "",
        "Melting Point": "150.1 Â°C"
    }
}